Products billed under this code include Diltiazem HCl, Diltiazem in Dextrose, Diltiazem in NaCl.
Payment limit per 0.5 MG, by effective quarter, 3Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Diltiazem HCl | Pfizer Inc | 00409-4350-03 | 2000 | $54.00 |
| Diltiazem HCl | Hikma Pharmaceuticals USA Inc. | 00641-6013-10 | 500 | $13.50 |
| Diltiazem HCl | Hikma Pharmaceuticals USA Inc. | 00641-6014-10 | 1000 | $27.00 |
| Diltiazem HCl | Hikma Pharmaceuticals USA Inc. | 00641-6015-10 | 2500 | $67.50 |
| Diltiazem HCl | Hikma Pharmaceuticals USA Inc. | 00641-9217-10 | 500 | $13.50 |
| Diltiazem HCl | Hikma Pharmaceuticals USA Inc. | 00641-9218-10 | 1000 | $27.00 |
| Diltiazem HCl | Hikma Pharmaceuticals USA Inc. | 00641-9219-10 | 2500 | $67.50 |
| Diltiazem HCl | Sagent Pharmaceuticals | 25021-0319-05 | 500 | $13.50 |
| Diltiazem HCl | Sagent Pharmaceuticals | 25021-0319-10 | 1000 | $27.00 |
| Diltiazem HCl | Sagent Pharmaceuticals | 25021-0319-25 | 2500 | $67.50 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Diltiazem HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1335-01 | 50 | $1.35 |
| Diltiazem HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1335-02 | 50 | $1.35 |
| Diltiazem HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1457-01 | 200 | $5.40 |
| Diltiazem HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1457-03 | 2000 | $54.00 |
| Diltiazem HCl | Eugia US LLC | 55150-0425-10 | 500 | $13.50 |
| Diltiazem HCl | Eugia US LLC | 55150-0426-10 | 1000 | $27.00 |
| Diltiazem HCl | Eugia US LLC | 55150-0427-10 | 2500 | $67.50 |
| Diltiazem HCl | Athenex Pharmaceutical Division, LLC | 70860-0301-05 | 500 | $13.50 |
| Diltiazem in Dextrose | Hikma Injectables USA Inc. | 63037-0119-05 | 1250 | $33.75 |
| Diltiazem in NaCl | Hikma Injectables USA Inc. | 63037-0117-05 | 1250 | $33.75 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.027 | −$0.001 | 0.5 MG | Inj, diltiazem hcl, 0.5 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.028 | −$0.012 | 0.5 MG | Inj, diltiazem hcl, 0.5 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.04 | $0.00 | 0.5 MG | Inj, diltiazem hcl, 0.5 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.04 | +$0.003 | 0.5 MG | Inj, diltiazem hcl, 0.5 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.037 | $0.00 | 0.5 MG | Inj, diltiazem hcl, 0.5 mg | v1, posted September 8, 2026 |
| 3Q25 | $0.037 | – | 0.5 MG | Inj, diltiazem hcl, 0.5 mg | v1, posted March 10, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
